Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

VistaGen Therapeutics Q4 EPS $(0.25) Up From $(0.30) YoY

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.25) per share. This is a 16.67 percent increase over losses of $(0.30) per share from the same period last year.

byBenzinga Newsdesk

June 23, 2022

1 minute read

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.25) per share. This is a 16.67 percent increase over losses of $(0.30) per share from the same period last year.